Jl. Mcdermott et al., Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: Long-term treatments, J NEUROENDO, 11(10), 1999, pp. 801-803
In the present report adult female rats were ovariectomized (OVX) and assig
ned to one of four treatment conditions. Treatments consisted of administer
ing pellets containing 17 beta-oestradiol (E), tamoxifen (TMX), a combinati
on of TMX and E or no further treatment (OVX), Animals received these treat
ments immediately following OVX and were maintained in these conditions for
a 40-day period. Subsequently, the corpus striatum (CS) was dissected from
each animal and prepared for determinations of basal and amphetamine stimu
lated DA output using in-vitro superfusion. No statistically significant di
fferences among the four treatment groups were obtained for basal dopamine
output. The highest levels of amphetamine-stimulated dopamine responses wer
e obtained from E treated rats. These values were significantly greater tha
n that obtained from OVX rats and rats treated with a combination of TMX E. The significance of these findings is that they indicate both a non-trad
itional central nervous system site and mechanism of action through which t
amoxifen-oestrogen interactions can function. Such data may have important
implications for administration of tamoxifen to premenopausal women as this
anti-oestrogen may compromise nigrostriatal dopaminergic function under co
nditions where oestrogenic modulation is present.